Sign in

Wei-Tse Hsu

@weitse-hsu.bsky.social
87 followers 309 following 10 posts

- Postdoc in Drug Design at Oxford Biochemistry (Biggin Lab). - Ph.D. from the Shirts Group at CU Boulder. - Keen on compchem, deep learning & education. - Rookie runner. - Originally from Taiwan. - Check my MD tutorials: weitsehsu.com

PostsRepliesMedia
Reposted by Wei-Tse Hsu
Joe Greener @jgreener64.bsky.social · 07/08/2026
Happy to play a small part in this perspective led by @andreasbender.bsky.social on where AI is in drug discovery, and what we should do in future. www.nature.com/articles/s41... Free link: rdcu.be/fyr77
nature.com
Artificial intelligence in drug discovery — what it is, where we stand and the path forward - Nature Reviews Drug Discovery
Applications of artificial intelligence (AI) in drug discovery have attracted high interest in recent years, but evidence for clinically relevant impact so far is limited. This Perspective discusses p...
041
Wei-Tse Hsu @weitse-hsu.bsky.social · 06/08/2026
🚨 Can AI reliably handle real-world, multi-step MD workflows comp chemists face every day? With Nithishwer Mouroug Anand and colleagues in the Biggin Lab @philbiggin.bsky.social @oxfordbiochemistry.bsky.social, we built MDArena from problems in active research projects. arxiv.org/abs/2608.02642
arxiv.org
MDArena: Evaluating Coding Agents on Realistic Molecular Dynamics Workflows
Accelerating scientific discovery is among the most consequential applications of AI, and computational biomolecular simulation stands out as a particularly promising target within this broader effort...
262
Reposted by Wei-Tse Hsu
Open Force Field @openforcefield.org · 05/08/2026
It's exciting to see real users testing agentic workflows that make use of our models and tools. Thanks to the Biggin lab for publicizing these results and showing the work that still needs to be done!
041
Reposted by Wei-Tse Hsu
Phil Biggin @philbiggin.bsky.social · 05/08/2026
Latest preprint where we pooled our sim experiences to create "MDArena" for AI agents trying to automate MD simulation and analysis. Great work led by Nithishwer Mouroug Anand and @weitse-hsu.bsky.social and thanks to all lab members! @oxfordbiochemistry.bsky.social arxiv.org/abs/2608.02642
arxiv.org
MDArena: Evaluating Coding Agents on Realistic Molecular Dynamics Workflows
Accelerating scientific discovery is among the most consequential applications of AI, and computational biomolecular simulation stands out as a particularly promising target within this broader effort...
0156
Reposted by Wei-Tse Hsu
Phil Biggin @philbiggin.bsky.social · 20/03/2026
Happy to see our work on SLCO2A1 with @smlea.bsky.social, Nakanishi and Newstead labs out now. Important insight into how prostaglandin and many drugs are transported. Hats off to @weitse-hsu.bsky.social for computational work! @oxfordbiochemistry.bsky.social www.nature.com/articles/s41...
nature.com
Structural basis for prostaglandin and drug transport via SLCO2A1
Nature Communications - SLCO2A1 (also known as OATP2A1) is responsible for the transport of eicosanoids, including prostaglandins (PGs), as well as of a subset of nonsteroidal anti-inflammatory...
13011
Reposted by Wei-Tse Hsu
Cole Group @colegroupncl.bsky.social · 27/01/2026
Now out in JACS! 🎉 : "Computing Solvation Free Energies of Small Molecules with Experimental Accuracy"! It's been a pleasure to collaborate on this with Harry Moore (@jhmchem.bsky.social) & Gábor Csányi pubs.acs.org/doi/10.1021/...
1298
Reposted by Wei-Tse Hsu
Stephanie Wankowicz @stephanieaw.bsky.social · 21/01/2026
New Preprint!! We show that binding entropy can be quantitatively predicted from crystallographic ensemble models, accounting for both protein conformational entropy and solvent entropy! www.biorxiv.org/content/10.6...
13914
Wei-Tse Hsu @weitse-hsu.bsky.social · 20/01/2026
📢 Can AI-Predicted Complexes Teach Machine Learning to Compute Drug Binding Affinity? In our recent JCIM work, we tested whether co-folding models can be used for data augmentation for training ML-based scoring functions (SFs). We asked 3 simple but critical questions. 👇 (1/6)
161